CLINICAL DOWNSTAGING AFTER NEOADJUVANT M-VAC FOR TRANSITIONAL CELL-CARCINOMA OF THE UROTHELIUM

被引：1
|
作者：
SCHER, HI
FAIR, WR
YAGODA, A
STERNBERG, CN
MORSE, MJ
HERR, HW
SOGANI, PC
HOLLANDER, PS
WHITMORE, WF
机构：
来源：
JOURNAL OF UROLOGY | 1987年 / 137卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(17)75363-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A157 / A157
页数：1
相关论文
共 50 条
  • [1] M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN) FOR ADVANCED TRANSITIONAL CELL-CARCINOMA OF THE UROTHELIUM
    STERNBERG, CN
    YAGODA, A
    SCHER, HI
    WATSON, RC
    HERR, HW
    MORSE, MJ
    SOGANI, PC
    VAUGHAN, ED
    BANDER, N
    WEISELBERG, LR
    GELLER, N
    HOLLANDER, PS
    LIPPERMAN, R
    FAIR, WR
    WHITMORE, WF
    JOURNAL OF UROLOGY, 1988, 139 (03): : 461 - 469
  • [2] HISTOPATHOLOGIC CHANGES OF TRANSITIONAL CELL-CARCINOMA OF BLADDER AFTER M-VAC CHEMOTHERAPY
    JAVADPOUR, N
    DALONI, P
    UROLOGY, 1989, 34 (06) : 357 - 359
  • [3] PRELIMINARY-RESULTS OF M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN) FOR TRANSITIONAL CELL-CARCINOMA OF THE UROTHELIUM
    STERNBERG, CN
    YAGODA, A
    SCHER, HI
    WATSON, RC
    AHMED, T
    WEISELBERG, LR
    GELLER, N
    HOLLANDER, PS
    HERR, HW
    SOGANI, PC
    MORSE, MJ
    WHITMORE, WF
    JOURNAL OF UROLOGY, 1985, 133 (03): : 403 - 407
  • [4] INITIAL EXPERIENCE WITH M-VAC FOR METASTATIC TRANSITIONAL CELL-CARCINOMA (TCC)
    SHEEHAN, R
    SAGALOWSKY, AI
    BALABAN, E
    COX, J
    JOURNAL OF UROLOGY, 1987, 137 (04): : A270 - A270
  • [5] M-VAC AS SALVAGE CHEMOTHERAPY IN TRANSITIONAL CELL-CARCINOMA (TCC) OF THE UROTHELIUM PREVIOUSLY TREATED WITH CISPLATIN COMBINATION CHEMOTHERAPY
    CHONG, C
    LOGOTHETIS, CJ
    DEXEUS, FH
    SELLA, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 204 - 204
  • [6] PATIENTS OF HIGH AGE WITH ADVANCED TRANSITIONAL CELL-CARCINOMA TREATED BY M-VAC CHEMOTHERAPY
    SAGASTER, P
    FLAMM, J
    ESSL, R
    TEICH, G
    AKTUELLE UROLOGIE, 1987, 18 (06) : 325 - 329
  • [7] M-VAC OR MVC FOR THE TREATMENT OF ADVANCED TRANSITIONAL CELL-CARCINOMA - METASTATIC, INDUCTION, AND ADJUVANT
    SOLOWAY, MS
    ISHIKAWA, S
    TAYLOR, T
    EZELL, G
    JOURNAL OF SURGICAL ONCOLOGY, 1989, : 40 - 45
  • [8] NEOADJUVANT M-VAC WITH INTRAARTERIAL (IA) CISPLATIN IN LOCALLY ADVANCED TRANSITIONAL CELL-CARCINOMA OF THE BLADDER - PHASE I/II TRIAL
    BUKOWSKI, RM
    MONTIE, JE
    LEE, M
    GANAPATHI, R
    JOURNAL OF UROLOGY, 1987, 137 (04): : A156 - A156
  • [9] Long-term results of neoadjuvant treatment with M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for locally invasive transitional cell carcinoma of the urothelium
    Miyake H.
    Gohji K.
    Hara I.
    Eto H.
    Yamanaka K.
    Arakawa S.
    Kamidono S.
    International Journal of Clinical Oncology, 1999, 4 (1) : 32 - 35
  • [10] NEOADJUVANT M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN) FOR INFILTRATING TRANSITIONAL-CELL CARCINOMA OF THE BLADDER
    STERNBERG, CN
    ARENA, MG
    CALABRESI, F
    DECARLI, P
    PLATANIA, A
    ZEULI, M
    GIANNARELLI, D
    CANCRINI, A
    PANSADORO, V
    CANCER, 1993, 72 (06) : 1975 - 1982
12345